SG3 Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,500
| Closed | -$259K | – | 24 |
|
|
2022
Q4 | $259K | Buy |
+2,500
| New | +$259K | 0.04% | 30 |
|
|
2022
Q3 | – | Sell |
-10,300
| Closed | -$854K | – | 104 |
|
|
2022
Q2 | $854K | Sell |
10,300
-1,700
| -14% | -$141K | 0.1% | 15 |
|
|
2022
Q1 | $925K | Sell |
12,000
-20,500
| -63% | -$1.58M | 0.03% | 68 |
|
|
2021
Q4 | $2.87M | Buy |
32,500
+7,500
| +30% | +$663K | 0.06% | 44 |
|
|
2021
Q3 | $1.93M | Buy |
25,000
+14,500
| +138% | +$1.12M | 0.06% | 28 |
|
|
2021
Q2 | $876K | Sell |
10,500
-8,100
| -44% | -$676K | 0.03% | 70 |
|
|
2021
Q1 | $1.4M | Sell |
18,600
-17,365
| -48% | -$1.31M | 0.04% | 65 |
|
|
2020
Q4 | $3.15M | Buy |
+35,965
| New | +$3.15M | 0.06% | 19 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 270 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 198 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 47 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 38 |
|